Your session is about to expire
← Back to Search
Phosphodiesterase Inhibitor
Cilostazol for Heart Failure
Phase 2
Waitlist Available
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
>18 yrs
LVEF ≥ 50% (on last assessment, <2 years)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1st and 3rd week
Awards & highlights
Study Summary
This study is evaluating whether a drug called cilostazol might improve symptoms and blood markers in people with heart failure with preserved ejection fraction.
Eligible Conditions
- Heart Failure
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1st and 3rd week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1st and 3rd week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
KCCQ-12
Secondary outcome measures
NTproBNP
Trial Design
2Treatment groups
Experimental Treatment
Group I: PlaceboExperimental Treatment2 Interventions
First week, Placebo twice a day
Second week, Cilostazol 100mg twice a day
Third week, Placebo twice a day
Forth week, Cilostazol 100mg twice a day
Group II: CilostazolExperimental Treatment2 Interventions
First week, Cilostazol 100mg twice a day
Second week, Placebo twice a day
Third week, Cilostazol 100mg twice a day
Forth week, Placebo twice a day
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cilostazol 100Mg Tab
2021
Completed Phase 2
~30
Placebo
1995
Completed Phase 3
~2670
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,367 Previous Clinical Trials
1,587,484 Total Patients Enrolled
10 Trials studying Heart Failure
5,736 Patients Enrolled for Heart Failure
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger